Yeah strange hey, add into that figure ongoing secure income. Biotechs are strange beasts. Penny stocks like this can be hard to get a sustainable lift in sp because a lot of holder are hanging on waiting for a certain price to bail so as soon as we get a jump those holders bail. As hd says, way to much retail hold. Once big end of town decide it's a buy then sp will rise dramatically. I think the trigger for that will be sustained cash flow positive which is a couple of years off yet. All in my opinion.
Ann: OCC Signs Striate Global License And Manufacturing Agreement, page-270
-
- There are more pages in this discussion • 29 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add OCC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
38.5¢ |
Change
0.005(1.32%) |
Mkt cap ! $80.59M | |||
| Open | High | Low | Value | Volume |
| 39.0¢ | 39.0¢ | 38.5¢ | $17.64K | 45.67K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 23269 | 38.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 39.5¢ | 25000 | 2 |
View Market Depth
| Last trade - 16.10pm 31/07/2024 (20 minute delay) ? |
| OCC (ASX) Chart |